A MECP2 missense mutation within the MBD domain in a Brazilian male with autistic disorder

Brain Dev. 2011 Nov;33(10):807-9. doi: 10.1016/j.braindev.2011.04.015. Epub 2011 May 19.

Abstract

Point mutations and genomic rearrangements in the MECP2 gene are the major cause of Rett syndrome (RTT), a pervasive developmental disorder affecting almost exclusively females. MECP2 mutations were also identified in patients with autism without RTT. In this study, we present a mutational and gene dosage analysis of the MECP2 in a cohort of 60 Brazilian males with autistic features but not RTT. No duplication or deletion was identified. Sequencing analysis, however, revealed four MECP2 sequence variations. Three of them were previously discussed as non disease causing mutations and one mutation (p.T160S) was novel. It affects a highly conserved amino acid located within the MBD domain, a region of the protein involved in specific recognition and interaction with methylated CpG dinucleotides. The p.T160S variation was not found in the control sample. This mutation may represent a potential genetic factor for autistic phenotype and should be object of further studies.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autistic Disorder / genetics*
  • Brazil
  • Child
  • CpG Islands / genetics
  • DNA Mutational Analysis
  • Humans
  • Male
  • Methyl-CpG-Binding Protein 2 / chemistry
  • Methyl-CpG-Binding Protein 2 / genetics*
  • Mutation, Missense / genetics*

Substances

  • MECP2 protein, human
  • Methyl-CpG-Binding Protein 2